Regulation and Action of SKP2 in Cell and Tumor Models: Mechanisms Underlying Aggressive Growth in Basal-Like Breast Cancer
Abstract
The objective of this research is to further our understanding of the molecular mechanisms underlying the aggressive growth of estrogen receptor (ER)-negative, basal-like breast tumors. My goal is to determine if SKP2 is a viable new therapeutic target to specifically treat patients who have tumors that are independent of ER signaling. The most significant result was determining that knockdown of SKP2 in TMX2-28 cells shifted the cell cycle resulting in a significant increase in the percentage of cells in the G1/G0 phase, as well as a significant decrease in the percentage of cells in the S-phase of the cell cycle.
Document Details
- Document Type
- Technical Report
- Publication Date
- Dec 01, 2011
- Accession Number
- ADA561142
Entities
People
- Katerina Fagan-solis
Organizations
- University of Massachusetts Amherst